Hilltop Partners LLC Endonovo Therapeutics, Inc. Transaction History

Hilltop Partners LLC

  • $331 Billion
  • Q2 2025

A detailed history of Hilltop Partners LLC transactions in Endonovo Therapeutics, Inc. stock. As of the latest transaction made, Hilltop Partners LLC holds 20,228 shares of ENDV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,228
Holding current value
$0
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 25, 2025
BUY
$0.0 - $0.0 $0 - $0
20,228 New
20,228 $3,000

Others Institutions Holding ENDV

# of Institutions
1
Shares Held
20.2K
Call Options Held
0
Put Options Held
0
View Full List

About ENDONOVO THERAPEUTICS, INC.

ENDV Quotes by TradingView
  • Ticker ENDV
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,478,000
  • Description
  • Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edem...
More about ENDV
Track This Portfolio

Track Hilltop Partners LLC Portfolio

Follow Hilltop Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hilltop Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hilltop Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email